Standard
CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus. / Hybel, Trine Engelbrecht; Vase, Maja Olholm; Lauridsen, Kristina Lystlund; Enemark, Marie Beck; Moller, Michael Boe; Pedersen, Court; Pedersen, Gitte; Hamilton-Dutoit, Stephen; Obel, Niels; Schade Larsen, Carsten; d'Amore, Francesco; Ludvigsen, Maja.
I:
Leukemia and Lymphoma, Bind 63, Nr. 6, 12.05.2022, s. 1479-1483.
Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt
Harvard
Hybel, TE, Vase, MO, Lauridsen, KL, Enemark, MB, Moller, MB, Pedersen, C, Pedersen, G, Hamilton-Dutoit, S
, Obel, N, Schade Larsen, C, d'Amore, F & Ludvigsen, M 2022, '
CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus',
Leukemia and Lymphoma, bind 63, nr. 6, s. 1479-1483.
https://doi.org/10.1080/10428194.2021.2023741APA
Hybel, T. E., Vase, M. O., Lauridsen, K. L., Enemark, M. B., Moller, M. B., Pedersen, C., Pedersen, G., Hamilton-Dutoit, S.
, Obel, N., Schade Larsen, C., d'Amore, F., & Ludvigsen, M. (2022).
CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus.
Leukemia and Lymphoma,
63(6), 1479-1483.
https://doi.org/10.1080/10428194.2021.2023741Vancouver
Hybel TE, Vase MO, Lauridsen KL, Enemark MB, Moller MB, Pedersen C o.a.
CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus.
Leukemia and Lymphoma. 2022 maj 12;63(6):1479-1483.
https://doi.org/10.1080/10428194.2021.2023741Author
Hybel, Trine Engelbrecht ; Vase, Maja Olholm ; Lauridsen, Kristina Lystlund ; Enemark, Marie Beck ; Moller, Michael Boe ; Pedersen, Court ; Pedersen, Gitte ; Hamilton-Dutoit, Stephen ; Obel, Niels ; Schade Larsen, Carsten ; d'Amore, Francesco ; Ludvigsen, Maja. / CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus. I: Leukemia and Lymphoma. 2022 ; Bind 63, Nr. 6. s. 1479-1483.
Bibtex
@article{1f293eace679417fb01eff5021529277,
title = "CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus",
keywords = "HIV, ACTIVATION, DEATH",
author = "Hybel, {Trine Engelbrecht} and Vase, {Maja Olholm} and Lauridsen, {Kristina Lystlund} and Enemark, {Marie Beck} and Moller, {Michael Boe} and Court Pedersen and Gitte Pedersen and Stephen Hamilton-Dutoit and Niels Obel and {Schade Larsen}, Carsten and Francesco d'Amore and Maja Ludvigsen",
year = "2022",
month = may,
day = "12",
doi = "10.1080/10428194.2021.2023741",
language = "English",
volume = "63",
pages = "1479--1483",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Taylor & Francis",
number = "6",
}
RIS
TY - JOUR
T1 - CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus
AU - Hybel, Trine Engelbrecht
AU - Vase, Maja Olholm
AU - Lauridsen, Kristina Lystlund
AU - Enemark, Marie Beck
AU - Moller, Michael Boe
AU - Pedersen, Court
AU - Pedersen, Gitte
AU - Hamilton-Dutoit, Stephen
AU - Obel, Niels
AU - Schade Larsen, Carsten
AU - d'Amore, Francesco
AU - Ludvigsen, Maja
PY - 2022/5/12
Y1 - 2022/5/12
KW - HIV
KW - ACTIVATION
KW - DEATH
U2 - 10.1080/10428194.2021.2023741
DO - 10.1080/10428194.2021.2023741
M3 - Comment/debate
C2 - 35019824
VL - 63
SP - 1479
EP - 1483
JO - Leukemia and Lymphoma
JF - Leukemia and Lymphoma
SN - 1042-8194
IS - 6
ER -
